Jack Harley

Writer

Jack Harley is a clinical neuroscience graduate with experience in the longevity biotechnology industry. Jack has worked with a clinical-stage pharmaceutical company to develop new therapeutics for cognitive impairment and neurodegenerative diseases, and lectured at the University of Oxford in clinical neuroscience. Jack is currently completing a PhD in aging and epigenetics at the University of New South Wales in Sydney, Australia.

Articles

An Introduction to the Longevity Industry: What it is, Growth & Companies

Editor’s Note: As the industry of longevity continues to expand and evolve in 2023 (see the 2022 milestones here), Spannr is dedicated to providing our readers with a comprehensive understanding of the field and all the exciting possibilities it holds. To that end, we invite you to consider the following as an introduction to the world ...

Join the Insiders Club.

Plain English. Every week. Free.

Includes the Longevity 101 guide and a one-page starter checklist. Unsubscribe any time.